Ampullary Cancer Clinical Trials

4 recruiting

Ampullary Cancer Trials at a Glance

13 actively recruiting trials for ampullary cancer are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Minya, Los Angeles, and Milan. Lead sponsors running ampullary cancer studies include Minia University, IRCCS San Raffaele, and George Zogopoulos.

Browse ampullary cancer trials by phase

Treatments under study

About Ampullary Cancer Clinical Trials

Looking for clinical trials for Ampullary Cancer? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ampullary Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ampullary Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Pancreatic CancerCholangiocarcinomaHepatocellular Carcinoma+3 more
University of California, Irvine15 enrolled1 locationNCT05497531
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 3

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Periampullary CancerPostoperative Pancreatic Fistula
Technische Universität Dresden32 enrolled1 locationNCT05843877
Recruiting
Phase 2

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

Pancreas CancerPeriampullary CancerPancreaticoduodenectomy+1 more
Minia University90 enrolled1 locationNCT07230509
Recruiting
Phase 3

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Pancreatic CancerCholangiocarcinomaPancreatic Ductal Adenocarcinoma+4 more
Minia University194 enrolled1 locationNCT07155525
Recruiting
Phase 1

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

Pancreas CancerPeriampullary CancerPancreaticoduodenectomy+1 more
Minia University30 enrolled1 locationNCT07132541
Recruiting
Phase 3

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Pancreas CancerPancreas AdenocarcinomaPancreatic Cancer Resectable+3 more
Minia University262 enrolled1 locationNCT07081360
Recruiting
Not Applicable

Laparoscopic Pancreaticoduodenectomy

Pancreatic CancerPancreatic FistulaPeriampullary Cancer
Minia University30 enrolled1 locationNCT07009119
Recruiting
Not Applicable

Prehabilitation in Pancreatic Surgery

Pancreatic CancerFrailty SyndromePerioperative/Postoperative Complications+2 more
IRCCS San Raffaele238 enrolled1 locationNCT06069297
Recruiting
Not Applicable

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

Pancreas CancerPancreas AdenocarcinomaPancreatic Fistula+4 more
Minia University100 enrolled1 locationNCT07022015
Recruiting

Quebec Pancreas Cancer Study

Pancreatic CancerPancreas CancerHereditary Cancer+8 more
George Zogopoulos2,000 enrolled1 locationNCT04104230
Recruiting

Prognostic Factors in Periampullary Tumors and Cysts

SurgeryPancreas CancerBile Duct Cancer+6 more
Umeå University500 enrolled1 locationNCT05155878
Recruiting
Phase 2

A study looking at the effect positron emission tomography (PET) scans have on the treatment decisions specialists make in patients with suspected cancer of the pancreas.

Pancreatic and peri-ampullary cancers.
Royal Brisbane Hospital90 enrolled1 locationACTRN12607000604404